To further test the association of HORMAD1 overexpression with tumor response to Rucaparib treatment in vivo, we generated several xenograft mouse models using BLBC cell lines engineered to ectopically overexpress HORMAD1 and assessed the tumors’ responses to Rucaparib treatment. This evidence concerns the gene HORMAD1 and neoplasm.